Suchergebnisse - "Farinas-Madrid, Lorena"

PubPharm (10)

1

Immunotherapy in the treatment of advanced or recurrent endometrial cancer

enthalten in: Clinical advances in hematology & oncology : H&O | 2024

von Grau-Bejar, J. | Farinas-Madrid, L. | García-Duran, C. | +3

2

Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc) : a randomised, open-label, phase 3 trial

enthalten in: Lancet (London, England) | 2024

von Oaknin, A. | Gladieff, L. | Martínez-García, J. | +117

3

Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Vergote, I. | Pérez-Fidalgo, J. | Hamilton, E. | +29

4

Advances in immunotherapy in cervical cancer

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2023

von Grau, J. | Farinas-Madrid, L. | Garcia-Duran, C. | +2

5

Phase 2 Trial (POLA Study) of Lurbinectedin plus Olaparib in Patients with Advanced Solid Tumors : Results of Efficacy, Tolerability, and the Translational Study

enthalten in: Cancers | 2022

von Poveda, A. | Lopez-Reig, R. | Oaknin, A. | +10

6

A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors

enthalten in: Scientific reports | 2021

von Poveda, A. | Oaknin, A. | Romero, I. | +6

7

EVOLVE : A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Lheureux, S. | Oaknin, A. | Garg, S. | +17

8

A randomized phase III trial of platinum chemotherapy plus paclitaxel with bevacizumab and atezolizumab versus platinum chemotherapy plus paclitaxel and bevacizumab in metastatic (stage IVB), persistent, or recurrent carcinoma of the cervix : the BEATcc study (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030)

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2020

von Grau, J. | Farinas-Madrid, L. | Oaknin, A.

9

Genomic heterogeneity and efficacy of PI3K pathway inhibitors in patients with gynaecological cancer

enthalten in: ESMO open | 2019

von Rodriguez-Freixinos, V. | Ruiz-Pace, F. | Fariñas-Madrid, L. | +6

10

Challenges in the management of neuroendocrine cervical cancer during pregnancy : A case report

enthalten in: Molecular and clinical oncology | 2018

von Gil-Ibañez, B. | Regueiro, P. | Llurba, E. | +3

1
[1]